-
-
Finance -
Pharma & Human Health -
Finance -
Pharma & Human Health
Editor’s Choice
Editor's Choice
Using a novel computational approach, researchers confirm microbial diversity is wilder than ever.
A new study published online October 11, 2023 in Nature highlights the vast array of functional diversity of microbes through a novel approach to better understand microbial communities by looking at protein function within them. […]
Editor's Choice
Pharmacomicrobiomics: The universe of microbiome-drug interactions
INTRODUCTION Every corner of the human body is inhabited by microbes, collectively known as the microbiome. Thousands of publications over the last decade have described how these microorganisms influence human physiology, health and disease, and […]
Editor's Choice
New standards in sensitivity and accuracy for microbiome research
Microbiome research promises to transform human health; however, until now the field has been held back by the challenges of translating microbiome data into novel treatments, ingredients, diagnostics, and other healthcare solutions. A number of […]
In Case you Missed it:
Finance
Boehringer Ingelheim acquires bacterial cancer therapy specialist T3 Pharma
Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma has developed a proprietary therapy […]
Pharma & Human Health
Initial patient dosed in Phase 2a clinical trial evaluating first-in-class human milk-based therapy
In a breakthrough for human milk science, researchers at City of Hope, Los Angeles, have dosed the first patient in a Phase 2a clinical trial evaluating a novel therapy for blood cancer patients undergoing allogeneic […]
Finance
Synlogic reports Q3 results, including underwritten public offering of $21.0M and $2.5M milestone payment from Roche
Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today reported financial results for the third quarter ended September 30, 2023, and provided […]
Pharma & Human Health
Mammalian cells may consume bacteria-killing viruses to promote cellular health
Bacteriophages are viruses that infect and kill bacteria, their natural hosts. But from a macromolecular viewpoint, phages can be viewed as nutritionally enriched packets of nucleotides wrapped in an amino acid shell. A study published […]
Pharma & Human Health
Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain
Health Canada authorizes functional claims that the probiotic strain DDS-1® “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adolescents and adults” The ‘gut-brain axis’ has become one of the most […]
Pharma & Human Health
MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company developing Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, announced that the first patient has been treated as part of its Phase […]
Finance
Seres Therapeutics announces strategic restructuring and third quarter financial results including VOWST™ net sales
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, reported on November 2nd financial results for the third quarter ended September 30, 2023, including VOWST net sales of $7.6 million. Third quarter VOWST commercial […]
Pharma & Human Health
Atopic dermatitis: Viruses discovered as new therapy option
Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or […]
